Organicell OTC Stock Financials

OCEL
 Stock
  

USD 0.0253  0.0007  2.69%   

We recommend to use Organicell Regenerative fundamental analysis to find out if markets are presently mispricing the firm. Put it differently this technique allows you to confirm available drivers of Organicell Regenerative as well as the relationship between them. We were able to analyze and collect data for twenty-nine available financial ratios for Organicell Regenerative, which can be compared to its competitors. To ensure the equity is not overpriced, please check all Organicell Regenerative financials, including its price to book, debt to equity, retained earnings, as well as the relationship between the ebitda and number of employees . As Organicell Regenerative appears to be a penny stock we also advise to check out its price to earning numbers. Use Organicell Regenerative to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Organicell Regenerative to be traded at $0.0243 in 90 days.
  
With this module, you can analyze Organicell financials for your investing period. You should be able to track the changes in Organicell Regenerative individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Organicell Most Recent Estimates

Diluted Eps
-0.005
Earnings Share
-0.005
Understanding current and past Organicell Regenerative Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Organicell Regenerative's financial statements are interrelated, with each one affecting the others. For example, an increase in Organicell Regenerative's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Less than 49
Organicell Regenerative Medicine has less than 49 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Organicell Regenerative otc stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Organicell Regenerative's official financial statements usually reflect Organicell Regenerative's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Organicell Regenerative. For example, before you start analyzing numbers published by Organicell accountants, it's critical to develop an understanding of what Organicell Regenerative's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Organicell Regenerative's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Organicell Regenerative's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Organicell Regenerative's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Organicell Regenerative Medicine. Please utilize our Beneish M Score to check the likelihood of Organicell Regenerative's management to manipulate its earnings.

Organicell Regenerative Company Summary

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida. Organicell Regenerative operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 22 people.
InstrumentUSA OTC Stock View All
ExchangeOTC Exchange
Business Address4045 Sheridan Avenue
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.organicell.com
Phone888 963 7881
CurrencyUSD - US Dollar
You should never invest in Organicell Regenerative without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Organicell OTC Stock, because this is throwing your money away. Analyzing the key information contained in Organicell Regenerative's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Organicell Regenerative Key Financial Ratios

Generally speaking, Organicell Regenerative's financial ratios allow both analysts and investors to convert raw data from Organicell Regenerative's financial statements into concise, actionable information that can be used to evaluate the performance of Organicell Regenerative over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Organicell Regenerative reports annually and quarterly.

Organicell Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Organicell Regenerative's current stock value. Our valuation model uses many indicators to compare Organicell Regenerative value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Organicell Regenerative competition to find correlations between indicators driving Organicell Regenerative's intrinsic value. More Info.
Organicell Regenerative Medicine is considered to be number one stock in total asset category among related companies. It is rated top company in revenue category among related companies totaling about  4.01  of Revenue per Total Asset. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Organicell Regenerative by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Organicell Regenerative's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organicell Regenerative's earnings, one of the primary drivers of an investment's value.

Organicell Regenerative Systematic Risk

Organicell Regenerative's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Organicell Regenerative volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Organicell Regenerative correlated with the market. If Beta is less than 0 Organicell Regenerative generally moves in the opposite direction as compared to the market. If Organicell Regenerative Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Organicell Regenerative is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Organicell Regenerative is generally in the same direction as the market. If Beta > 1 Organicell Regenerative moves generally in the same direction as, but more than the movement of the benchmark.
.

About Organicell Regenerative Financials

What exactly are Organicell Regenerative Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Organicell Regenerative's income statement, its balance sheet, and the statement of cash flows. Potential Organicell Regenerative investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Organicell Regenerative investors may use each financial statement separately, they are all related. The changes in Organicell Regenerative's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Organicell Regenerative's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines that you should keep in mind when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase year after year due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt to equity ratio because this number will tell you how much risk it has. If a company such as Organicell Regenerative is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to try and figure out if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that net revenue of Organicell grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only grown by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Organicell Regenerative August 16, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Organicell Regenerative help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Organicell Regenerative Medicine. We use our internally-developed statistical techniques to arrive at the intrinsic value of Organicell Regenerative Medicine based on widely used predictive technical indicators. In general, we focus on analyzing Organicell OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Organicell Regenerative's daily price indicators and compare them against related drivers.
Downside Deviation12.19
Information Ratio0.0557
Maximum Drawdown54.66
Value At Risk(11.43)
Potential Upside16.13
Please check Your Equity Center. Note that the Organicell Regenerative information on this page should be used as a complementary analysis to other Organicell Regenerative's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Organicell OTC Stock analysis

When running Organicell Regenerative price analysis, check to measure Organicell Regenerative's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organicell Regenerative is operating at the current time. Most of Organicell Regenerative's value examination focuses on studying past and present price action to predict the probability of Organicell Regenerative's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Organicell Regenerative's price. Additionally, you may evaluate how the addition of Organicell Regenerative to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Is Organicell Regenerative's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organicell Regenerative. If investors know Organicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organicell Regenerative listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
29.6 M
Quarterly Revenue Growth YOY
0.45
Return On Assets
-1.86
The market value of Organicell Regenerative is measured differently than its book value, which is the value of Organicell that is recorded on the company's balance sheet. Investors also form their own opinion of Organicell Regenerative's value that differs from its market value or its book value, called intrinsic value, which is Organicell Regenerative's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organicell Regenerative's market value can be influenced by many factors that don't directly affect Organicell Regenerative's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organicell Regenerative's value and its price as these two are different measures arrived at by different means. Investors typically determine Organicell Regenerative value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organicell Regenerative's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.